Is CERUS CORP (CERS) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2025
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 26.5% / 30% | 21.7% / 30% | 8.0% / 30% | 1.3% / 5% | ✓ HALAL |
| DJIM | 26.5% / 33% | 21.7% / 33% | 8.0% / 33% | 1.3% / 5% | ✓ HALAL |
| MSCI | 48.8% / 33% | 40.0% / 33% | 14.8% / 33% | 1.3% / 5% | ✗ NOT HALAL |
| S&P | 26.5% / 33% | 21.7% / 33% | 8.0% / 33% | 1.3% / 5% | ✓ HALAL |
| FTSE | 48.8% / 33% | 40.0% / 33% | 14.8% / 50% | 1.3% / 5% | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 54.5% | |
| Operating Margin | -1.1% | |
| Net Margin | -7.6% | |
| Return on Equity (ROE) | -25.7% | |
| Return on Assets (ROA) | -2.6% |
Cash Flow & Balance Sheet
| Operating Cash Flow | $5M |
| Free Cash Flow | $1M |
| Total Debt | $97M |
| Debt-to-Equity | 149.2 |
| Current Ratio | 1.7 |
| Total Assets | $222M |
Price & Trading
| Last Close | $1.83 |
| 50-Day MA | $2.19 |
| 200-Day MA | $1.72 |
| Avg Volume | 1.7M |
| Beta | 1.5 |
|
52-Week Range
$1.12
| |
About CERUS CORP (CERS)
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. The company offers INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company also offers INTERCEPT Blood Systems for platelets plasma, and cryoprecipitation, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells intended for transfusion; INTERCEPT Blood System for Cryoprecipitation that uses its plasma system to produce pathogen reduced cryoprecipitated fibrinogen complex for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, as well as pathogen reduced plasma and cryoprecipitate reduced; and INTERCEPT Illuminator, an LED-based device for blood component treatment. It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. The company was formerly known as CERUS TECHNOLOGIES INC and changed its name to Cerus Corporation in July 1996. The company was incorporated in 1991 and is headquartered in Concord, California.
Purification Calculator
As a halal stock with 1.30% impermissible income, you need to purify your dividends.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is CERUS CORP (CERS) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), CERUS CORP is Halal. The company passes all financial ratio thresholds for debt, cash, receivables, and impermissible income. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is CERUS CORP's debt ratio?
CERUS CORP's debt ratio is 26.5% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 48.8%.
Does CERUS CORP require dividend purification?
Yes, CERUS CORP has an impermissible income ratio of 1.30%, which means 1.30% of any dividends received should be donated to charity as purification. This is because a small portion of the company's revenue comes from non-Shariah-compliant sources.
What are CERUS CORP's key financial metrics?
CERUS CORP has a market capitalization of $342M, and revenue of $206M. The company maintains a gross margin of 54.5% and a net margin of -7.6%. Return on equity stands at -25.7%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.